[1]
L. J. Rojas Melo, K. H. Ojeda Rodríguez, A. L. Kerguelen Villadiego, and D. A. . Parra Prieto, “Hypophysitis and secondary adrenal insufficiency associated with Pembrolizumab”, Rev.ACE, vol. 8, no. 4, Feb. 2022.